HighVista Strategies »

Abivax SA F shares owned by HighVista Strategies

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $826k 58k 14.30

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Apogee Therapeutics (APGE)
Spyre Therapeutics Com New (SYRE)
Merus N V (MRUS)
Microsoft Corporation (MSFT)
Arcellx Common Stock (ACLX)
Xpo Logistics Inc equity (XPO)
Nuvalent Inc-a (NUVL)
Ansys (ANSS)
Hess (HES)
Ideaya Biosciences (IDYA)
Juniper Networks (JNPR)
Sp Plus (SP)
Cerevel Therapeutics Hldng I (CERE)
Albertsons Cos Common Stock (ACI)

View all positions for HighVista Strategies

Top funds holding Abivax SA F

Dr. Jeffrey R. Jay, M.D.
Cormorant Asset Management
Blackstone Group
Commodore Capital
Franklin Resources
VR Adviser
Nantahala Capital Management
Henderson Group
Samsara BioCapital
Saturn V Capital Management
Morgan Stanley
Citadel Advisors
Adage Capital Partners GP
Point72 Asset Management
Rosalind Advisors

View all funds holding Abivax SA F